Navigation Links
SNM applauds temporary freeze on Medicare cuts
Date:4/16/2010

RESTON, Va.On April 16, the President signed a bill granting temporary relief from looming cuts to Medicare reimbursement rates. Although a positive step, the medical communityalong with millions of patientscontinues to face significant threats to medical coverage for critical diagnostic imaging tests and therapeutics.

"This is good news, and we are encouraged that the President has signed a bill to delay reimbursement cuts to medical imaging," said Michael M. Graham, Ph.D., M.D., president of SNM. "This extension may have bought us a little more time, but we are still in great need of a long-term solution that does not block access to medical services for Medicare patients."

Graham added that the danger to the medical community is "very real" and advises that a long-term fix is needed to solve this persistent threat. "We urge Congress to take action now to stop this waiting game and ensure access to the tests patients need."

"Medical imaging has come under greater threat than any other medical service," said Robert W. Atcher, Ph.D., M.B.A., chair of SNM's Government Relations Committee. "Nuclear medicine has seen greater cuts than other imaging modalities and is poised on the brink of disaster. It is a disservice to our profession and the patients we serve not to reimburse these tests at adequate levels."

This recent short-term fix delays cuts to medical imaging through June 1, by which time Congress will have to take further action to ensure access for patients. After the temporary fix expires, physicians will once again face severe cuts in the level of reimbursement they receive for caring for Medicare patients. In the past, Congress has failed to approve a permanent fix to the Sustainable Growth Rare (SGR), instead passing a series of one-year patches to prevent proposed cuts. After the temporary fix expires, physicians will once again face severe cuts in the level of reimbursement they receive for caring for Medicare patients.

More than 20 million men, women, and children have noninvasive molecular imaging procedures annually. These safe, cost-effective procedures include positron emission tomography (PET) scans to diagnose and monitor treatment of cancer, cardiac stress tests to assess coronary artery disease, bone scans for orthopedic injuries, and lung scans to detect blood clots. Patients also undergo procedures to diagnose abnormal liver and gall bladder function and to diagnose and treat hyperthyroidism and thyroid cancer. The advances in imaging technology have significantly reduced the need for exploratory surgery and have changed how physicians diagnose and treat many of our most serious diseases.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. The Arc Applauds House Passage of Health Care Reform Legislation
2. Pew Applauds Federal Grant Program Supporting State Expansion of Evidence-Based Home Visitation
3. National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Reconciliation Bill
4. ISSA Applauds Cincinnati Trainer Anthony Reed for Dedication to Health Awareness
5. First Personal Injury Applauds HSE Campaign
6. DNC Chairman Tim Kaine Applauds President, Members of Congress on Todays Bipartisan Summit
7. MARC Coalition Applauds Agencys Alert Regarding Delay in Data Exchange Deadline
8. IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support
9. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
10. Alzheimers Association Applauds Social Security Administration for Adding Early-Onset Alzheimers to Its Compassionate Allowances Initiative
11. Veterans Affairs Employee Union Applauds Proposed Increases for Veterans Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: